1. Home
  2. PTMN vs CRBU Comparison

PTMN vs CRBU Comparison

Compare PTMN & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTMN
  • CRBU
  • Stock Information
  • Founded
  • PTMN 2006
  • CRBU 2011
  • Country
  • PTMN United States
  • CRBU United States
  • Employees
  • PTMN N/A
  • CRBU N/A
  • Industry
  • PTMN Finance: Consumer Services
  • CRBU Medicinal Chemicals and Botanical Products
  • Sector
  • PTMN Finance
  • CRBU Health Care
  • Exchange
  • PTMN Nasdaq
  • CRBU Nasdaq
  • Market Cap
  • PTMN 107.9M
  • CRBU 93.0M
  • IPO Year
  • PTMN N/A
  • CRBU 2021
  • Fundamental
  • Price
  • PTMN $12.62
  • CRBU $1.26
  • Analyst Decision
  • PTMN Hold
  • CRBU Strong Buy
  • Analyst Count
  • PTMN 1
  • CRBU 4
  • Target Price
  • PTMN $14.00
  • CRBU $8.50
  • AVG Volume (30 Days)
  • PTMN 39.6K
  • CRBU 1.8M
  • Earning Date
  • PTMN 08-07-2025
  • CRBU 08-05-2025
  • Dividend Yield
  • PTMN 15.53%
  • CRBU N/A
  • EPS Growth
  • PTMN N/A
  • CRBU N/A
  • EPS
  • PTMN N/A
  • CRBU N/A
  • Revenue
  • PTMN $58,024,000.00
  • CRBU $9,918,000.00
  • Revenue This Year
  • PTMN N/A
  • CRBU $12.83
  • Revenue Next Year
  • PTMN $12.20
  • CRBU N/A
  • P/E Ratio
  • PTMN N/A
  • CRBU N/A
  • Revenue Growth
  • PTMN N/A
  • CRBU N/A
  • 52 Week Low
  • PTMN $11.48
  • CRBU $0.66
  • 52 Week High
  • PTMN $19.95
  • CRBU $3.00
  • Technical
  • Relative Strength Index (RSI)
  • PTMN 59.82
  • CRBU 55.31
  • Support Level
  • PTMN $12.34
  • CRBU $1.20
  • Resistance Level
  • PTMN $12.75
  • CRBU $1.44
  • Average True Range (ATR)
  • PTMN 0.24
  • CRBU 0.11
  • MACD
  • PTMN 0.14
  • CRBU -0.00
  • Stochastic Oscillator
  • PTMN 88.98
  • CRBU 55.00

About PTMN Portman Ridge Finance Corporation

Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: